Gentamicin

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Gentamicin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  1. Serious infections caused by susceptible strains of organism.
    1. With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for serious infections.
  2. Bacterial septicemia, including neonatal sepsis
  3. Skin, bone and soft tissue infections (including burns)
  4. Meningitis (poor penetration)
  5. Urinary tract
  6. Respiratory tract (poor penetration)
  7. Gastrointestinal tract (including peritonitis)
  8. Inflammatory ocular conditions that are steroid-responsive (opthalmic ointment and suspension)

NON-FDA APPROVED USES

  1. Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
  2. Intra-abdominal infection (in combination with an agent with Gram-positive and anaerobe coverage)
  3. Enterococcal endocarditis (in combination with ampicillin)
  4. Pelvic inflammatory disease (PID, in combination with clindamycin)
  5. Infections caused by P. aeruginosa (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
  6. Brucella Species

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  1. Serious infections caused by susceptible strains of organism.
    1. With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for serious infections.
  2. Bacterial septicemia, including neonatal sepsis
  3. Skin, bone and soft tissue infections (including burns)
  4. Meningitis (poor penetration)
  5. Urinary tract
  6. Respiratory tract (poor penetration)
  7. Gastrointestinal tract (including peritonitis)
  8. Inflammatory ocular conditions that are steroid-responsive (opthalmic ointment and suspension)

NON-FDA APPROVED USES

  1. Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
  2. Intra-abdominal infection (in combination with an agent with Gram-positive and anaerobe coverage)
  3. Enterococcal endocarditis (in combination with ampicillin)
  4. Pelvic inflammatory disease (PID, in combination with clindamycin)
  5. Infections caused by P. aeruginosa (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
  6. Brucella Species

There's more to see -- the rest of this entry is available only to subscribers.